Track Every Presidential Action. Understand the Impact.
AI-powered summaries of executive orders, proclamations, and memoranda.
Type
Unlocking Cures for Pediatric Cancer With Artificial Intelligence
On September 30, 2025, President Donald Trump issued Executive Order 14355, titled "Unlocking Cures for Pediatric Cancer With Artificial Intelligence." This order directs the Make America Healthy Again (MAHA) Commission to collaborate with various federal entities to harness AI technology in combating pediatric cancer, which remains the leading cause of disease-related death among children in the U.S. The initiative aims to improve data infrastructure, enhance predictive modeling, and optimize clinical trials through AI, building on the existing Childhood Cancer Data Initiative. The order also emphasizes increasing federal investment and encouraging private sector engagement in AI-driven pediatric cancer research, while ensuring patient data privacy and interoperability.
Stay up to date on presidential actions
New executive orders and proclamations, straight to your inbox.
Sep 30, 2025
Unlocking Cures for Pediatric Cancer with Artificial Intelligence
Jul 24, 2025
Ending Crime and Disorder on America’s Streets
May 14, 2025
FRKeeping Promises to Veterans and Establishing a National Center for Warrior Independence
May 08, 2025
FRRegulatory Relief To Promote Domestic Production of Critical Medicines
May 05, 2025
Regulatory Relief to Promote Domestic Production of Critical Medicines
President Donald Trump issued an order to streamline regulations for domestic pharmaceutical manufacturing to enhance national security and reduce dependency on foreign sources. The order directs the Secretary of Health and Human Services and the FDA Commissioner to review and eliminate unnecessary regulations that hinder the development of pharmaceutical manufacturing in the United States. It also calls for improvements in the inspection processes for both domestic and foreign manufacturing facilities. Additionally, the Environmental Protection Agency and the U.S. Army Corps of Engineers are tasked with updating their regulations to facilitate faster approval and expansion of manufacturing facilities. This action aims to make the U.S. a more competitive environment for the production of essential medicines.